dibetes
Conditions
Interventions
SGLT2 inhibitors group:None
Non-SGLT2 inhibitors group:None
Sponsors
Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Chinese, no gender limit, aged 18-80 years; 2. Meet the clinical diagnosis of type 2 diabetes mellitus; 3. Meet the clinical diagnosis of acute myocardial infarction; 4. In addition to lifestyle intervention, diabetes mellitus requires at least one hypoglycemic drug treatment (including sulfonylureas, metformin, acarbose, Voglibose, thiazolidinediones, glienides, DPP4 inhibitors, GLP-1 receptor agonists, insulin, etc.); Since most patients with acute myocardial infarction are complicated with heart failure, drugs contraindicated or carefully used for acute myocardial infarction and heart failure should be avoided during treatment, such as thiazolidinediones (pioglitazone, rosiglitazone), DPP4 inhibitors (saxagliptin, alogliptin), metformin, etc.; 5. The patient has clear consciousness and can satisfy normal communication; 6. Good compliance, able to understand and implement the doctor's advice.
Exclusion criteria
Exclusion criteria: Glomerular filtration rate (eGFR) < 45mL/min/1.73m^2.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| left ventricular end-systolic volume index; | — |
Secondary
| Measure | Time frame |
|---|---|
| left ventricular mass;markers of myocardial infarction;cardiovascular event; | — |
Countries
China
Contacts
Public ContactShen Long
Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Outcome results
None listed